PV & RM Services,
Mr. Axel Hagel has over 21 years of experience in the life sciences industry, specializing in the deployment of drug safety applications in North America, Europe, and Japan. He has unique experience and implementation skills for the Argus Safety Suite, including Argus J, and is recognized in the drug safety sector as a Pharmacovigilance industry leader. Prior to IQVIA, Mr. Hagel served as the North American Practice Partner at Deloitte, and as Vice President of Drug Safety at Relsys International, Inc., the developer of Argus Safety Suite before its acquisition by Oracle. Mr. Hagel completed his Bachelor of Computer Science with High Honors at Carleton University in Ottawa, Canada.